MPM Capital

Investor type

PE / VC

Founded

1996

AUM

$3 000 M

Location

Boston, Massachusetts, United States

$0-1 m

Investment Ticket

3-5 years

Investment Horizon

Seed, Series B, Series A

Investment Stage

Sale to strategic investor, IPO

Exit Strategy

Investor profile last updated: 27 July, 2026

Profile

MPM Capital is a world-leading biotechnology investment firm with nearly three decades of experience creating and investing in companies that seek to translate scientific innovations into cures for major diseases. With its world-class team and deep experience in scientific research, clinical development, and company-building, MPM strives to power novel medical breakthroughs that transform patients’ lives. MPM invests across the biotech landscape with early-stage venture capital funds, and with impact and public equities products through its affiliate BioImpact Capital.

Industry

Life Sciences Healthcare Services Technology MedTech AI Software Medical Devices Biotechnology HealthTech Financial Services Fintech

Region of investment

North America Europe

MPM Capital Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
MPM Bio 2014 NVS Strategic Fund
Venture Capital (VC)
Biotechnology
Healthcare Services
Medical Devices
HealthTech
Pre-seed
Seed
Series A
North America
Europe
$5-10 m
$54 M
June 2014
MPM BioVentures 2014 LP
Venture Capital (VC)
Biotechnology
Financial Services
Fintech
Healthcare Services
Medical Devices
Pre-seed
Seed
Series A
North America
Europe
$5-10 m
$351 M
May 2015
MPM Oncology Impact Fund I
Venture Capital (VC)
Biotechnology
Financial Services
Fintech
Medical Devices
Pre-seed
Seed
Series A
North America
$5-10 m
$471 M
May 2016
MPM Oncology Innovations Fund
Venture Capital (VC)
Biotechnology
Financial Services
Fintech
Healthcare Services
Medical Devices
Pre-seed
Seed
Series A
North America
Europe
$5-10 m
$100 M
February 2019

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
8jD1nZCciPNaAgvs 8jD1nZCciPNaAgvs
8jD1nZCciPNaAgvs
avatar
8jD1nZCciPNaAgvs 8jD1nZCciPNaAgvs
8jD1nZCciPNaAgvs
avatar
8jD1nZCciPNaAgvs 8jD1nZCciPNaAgvs
8jD1nZCciPNaAgvs
avatar
8jD1nZCciPNaAgvs 8jD1nZCciPNaAgvs
8jD1nZCciPNaAgvs
avatar
8jD1nZCciPNaAgvs 8jD1nZCciPNaAgvs
8jD1nZCciPNaAgvs
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!

FAQs about MPM Capital

MPM Capital is located in Boston, Massachusetts, United States.
MPM Capital was founded in 1996.
MPM Capital invests in companies and startups in Life Sciences, Healthcare Services, Technology, MedTech, AI, Software, Medical Devices, Biotechnology, HealthTech, Financial Services, Fintech.
MPM Capital invests in companies and startups in North America, Europe.
MPM Capital invests in companies and startups at Seed, Series B, Series A.
MPM Capital usually invests $0-1 m on average.
MPM Capital has around $3 000m assets under management.
MPM Capital last fund was created/launched in 2019-02-27